SCHEMBL4070097

SCHEMBL4070097

FC(F)(F)c1ccccc1N1C[CH]CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.46
TTR P02766 1/20 0.43
DRD4 P21917 1/20 0.42
GRM2 Q14416 1/20 0.42
HSD11B1 P28845 2/20 0.42
TRPV1 Q8NER1 6/20 0.41
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
PMP22 Q01453 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RBP4 P02753 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069223 0.90 AKR1C3 (0.43) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL4064652 0.89 AKR1C3 (0.51) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL6914239 0.86 AKR1C3 (0.46) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL4792071 0.79 AKR1C3 (0.51) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL23211918 0.77 AKR1C3 (0.54) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL30407607 0.77 AKR1C3 (0.54) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL22669019 0.77 AKR1C3 (0.54) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL27647544 0.76 AKR1C3 (0.53) AKR1C3TTRDRD4GRM2HSD11B1
SCHEMBL4072195 0.76 SMN1; SMN2 (0.46) DRD4KMT2AALDH1A1MEN1LMNA
SCHEMBL28305284 0.74 NOTUM (0.52) AKR1C3TTRDRD4GRM2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337787-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS Changzhou Jiekai Pharmatech Co. Ltd. (CN) 2018-06-27 EP claimed
WO-2017028314-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS CHANGZHOU JIEKAI PHARMATECH CO., LTD. (CN) 2017-02-23 WO claimed
EP-3337787-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS Changzhou Jiekai Pharmatech Co. Ltd. (CN) 2018-06-27 EP disclosed
WO-2017028314-A1 PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS CHANGZHOU JIEKAI PHARMATECH CO., LTD. (CN) 2017-02-23 WO disclosed
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed